pemirolast inn mast cell stabilizer used antiallergic drug therapy marketed tradenames alegysal alamast clinical trials studying treatments allergic conjunctivitis found ophthalmic solution containing levocabastine pemirolast potassium may effective alleviating symptoms levocabastine also studied treatment asthma pemirolast appeared possible candidate spike protein disruption interference results ascertained molecular dynamics calculations executed summit supercomputer simulating compounds fda similar regulatory approval authors found interfacial molecules could potentially disrupt interface receptors suggesting small molecules could mitigate infection candidate interfacial molecules included pemirolast isoniazid pyruvate nitrofurantoin drug article relating respiratory system stub help wikipedia expanding ithttpsenwikipediaorgwikipemirolast